APPROVAL OF GUIDANT DEAL EXPECTED

Shareholders are expected to vote overwhelmingly to approve Boston Scientific's proposed $27 billion takeover of Guidant in separate meetings this morning at their headquarters.

The New York Times (http://www.nytimes.com/2006/03/31/business/31device.html?_r=1&oref=slogin)